Javascript must be enabled to continue!
Mecp2 Fine-tunes Quiescence Exit by Targeting Nuclear Receptors
View through CrossRef
Abstract
Quiescence (G0) maintenance and exit are crucial for tissue homeostasis and regeneration in mammals. Here, we show that methyl-CpG binding protein 2 (Mecp2) expression is cell cycle-dependent and negatively regulates quiescence exit in cultured cells and in an injury-induced liver regeneration mouse model. Specifically, acute reduction of Mecp2 is required for efficient quiescence exit, as deletion of Mecp2 accelerates, while overexpression of Mecp2 delays quiescence exit, and forced expression of Mecp2 after Mecp2 conditional knockout rescues cell cycle reentry. The E3 ligase Nedd4 mediates the ubiquitination and degradation of Mecp2, and thus facilitates quiescence exit. Genome-wide study uncovered the dual role of Mecp2 in preventing quiescence exit by transcriptionally activating metabolic genes while repressing proliferation-associated genes. Particularly, disruption of two nuclear receptors (NRs), Rara or Nr1h3, accelerates quiescence exit, mimicking the Mecp2 depletion phenotype. Our studies unravel a previously unrecognized role for Mecp2 as an essential regulator of quiescence exit and tissue regeneration.
eLife Sciences Publications, Ltd
Title: Mecp2 Fine-tunes Quiescence Exit by Targeting Nuclear Receptors
Description:
Abstract
Quiescence (G0) maintenance and exit are crucial for tissue homeostasis and regeneration in mammals.
Here, we show that methyl-CpG binding protein 2 (Mecp2) expression is cell cycle-dependent and negatively regulates quiescence exit in cultured cells and in an injury-induced liver regeneration mouse model.
Specifically, acute reduction of Mecp2 is required for efficient quiescence exit, as deletion of Mecp2 accelerates, while overexpression of Mecp2 delays quiescence exit, and forced expression of Mecp2 after Mecp2 conditional knockout rescues cell cycle reentry.
The E3 ligase Nedd4 mediates the ubiquitination and degradation of Mecp2, and thus facilitates quiescence exit.
Genome-wide study uncovered the dual role of Mecp2 in preventing quiescence exit by transcriptionally activating metabolic genes while repressing proliferation-associated genes.
Particularly, disruption of two nuclear receptors (NRs), Rara or Nr1h3, accelerates quiescence exit, mimicking the Mecp2 depletion phenotype.
Our studies unravel a previously unrecognized role for Mecp2 as an essential regulator of quiescence exit and tissue regeneration.
Related Results
Dose-dependent nuclear delivery and transcriptional repression with a cell-penetrant MeCP2
Dose-dependent nuclear delivery and transcriptional repression with a cell-penetrant MeCP2
Abstract
Methyl-CpG-binding-protein 2 (MeCP2) is a nuclear protein expressed in all cell types, especially neurons
1
...
Etude des déficits catécholaminergiques centraux chez la souris Mecp2-déficiente, modèle murin du syndrome de Rett
Etude des déficits catécholaminergiques centraux chez la souris Mecp2-déficiente, modèle murin du syndrome de Rett
La méthylation de l’ADN est une modification majeure du génome des eucaryotes permettant de moduler l’expression génique et contrôler le développement des mammifères. La protéine M...
Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain
Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain
AbstractMeCP2 is an abundant protein, involved in transcriptional repression by binding to CG and non-CG methylated DNA. However, MeCP2 might also function as a transcription activ...
Integrative analyses of transcriptome and DNA methylome from human neurons expressing multiple MECP2 levels
Integrative analyses of transcriptome and DNA methylome from human neurons expressing multiple MECP2 levels
Rett Syndrome (RTT) is a monogenic disorder, which mainly affects girls and is caused by mutations in methyl-CpG- binding protein 2 (MECP2). It is characterized by symptoms like lo...
MeCP2 controls dendritic morphogenesis via miR-199a-mediated Qki downregulation
MeCP2 controls dendritic morphogenesis via miR-199a-mediated Qki downregulation
Abstract
Rett syndrome (RTT) (OMIM: 312750) is a severe neurodevelopmental disorder caused by mutations in the
MECP2
...
An insertion mutation of the MECP2 gene in severe neonatal encephalopathy and ocular and oropharyngeal dyskinesia: a case report
An insertion mutation of the MECP2 gene in severe neonatal encephalopathy and ocular and oropharyngeal dyskinesia: a case report
Abstract
Background
Pathogenic variation of the MECP2 gene presents mostly as Rett syndrome in females and is extremely rare in males. Most male pat...
MeCP2 regulates gene expression through recognition of H3K27me3
MeCP2 regulates gene expression through recognition of H3K27me3
AbstractMeCP2 plays a multifaceted role in gene expression regulation and chromatin organization. Interaction between MeCP2 and methylated DNA in the regulation of gene expression ...
MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
AbstractBackgroundRett syndrome (RTT) is a neurodevelopmental disorder that predominantly affects girls. Its causative gene is the X‐linked MECP2 encoding the methyl‐CpG‐binding pr...

